Onkologic Inc.

Cell culture media products for best-in-class quality of Natural Killer cell immunotherapies for Oncology, through a novel formulation using plant extracts.

  • Stage Product In Market
  • Industry Biotechnology
  • Location Worcester, MA, USA
  • Currency USD
  • Founded July 2021
  • Employees 1
  • Incorporation Type C-corp
  • Website onkologic.com

Company Summary

Onkologic Inc offers a novel portfolio of cell-culture media products for Natural Killer (NK) cell immunotherapy in Oncology, a domain with rapid growth (20% CAGR). IP-protected and developed under an NIH grant, our products support the biomanufacturing of NK cells with enhanced quality and consistent anticancer potency, a crucial unmet need. A risk-mitigated regulatory path and strong traction with early adopters offer an attractive investment.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free